SE7601096L - Forfarande for framstellning av preparat for oral administration - Google Patents

Forfarande for framstellning av preparat for oral administration

Info

Publication number
SE7601096L
SE7601096L SE7601096A SE7601096A SE7601096L SE 7601096 L SE7601096 L SE 7601096L SE 7601096 A SE7601096 A SE 7601096A SE 7601096 A SE7601096 A SE 7601096A SE 7601096 L SE7601096 L SE 7601096L
Authority
SE
Sweden
Prior art keywords
oral administration
bitter taste
bitter
active ingredient
procedure
Prior art date
Application number
SE7601096A
Other languages
Unknown language ( )
English (en)
Other versions
SE418146B (sv
Inventor
T Kobayashi
A Okada
T Mayama
Original Assignee
Meiji Seika Kaisha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Seika Kaisha filed Critical Meiji Seika Kaisha
Publication of SE7601096L publication Critical patent/SE7601096L/sv
Publication of SE418146B publication Critical patent/SE418146B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7601096A 1975-09-29 1976-02-02 Forfarande for framstellning av preparat for oral administration utan bittersmak SE418146B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP50117513A JPS5840529B2 (ja) 1975-09-29 1975-09-29 ケイコウヨウセイザイノセイホウ

Publications (2)

Publication Number Publication Date
SE7601096L true SE7601096L (sv) 1977-03-30
SE418146B SE418146B (sv) 1981-05-11

Family

ID=14713609

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7601096A SE418146B (sv) 1975-09-29 1976-02-02 Forfarande for framstellning av preparat for oral administration utan bittersmak

Country Status (11)

Country Link
US (1) US4101651A (sv)
JP (1) JPS5840529B2 (sv)
BE (1) BE838239A (sv)
CA (1) CA1069047A (sv)
DE (1) DE2604044C2 (sv)
ES (1) ES445014A1 (sv)
FR (1) FR2325388A1 (sv)
GB (1) GB1539076A (sv)
MX (1) MX4338E (sv)
NL (1) NL167325C (sv)
SE (1) SE418146B (sv)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54107515A (en) * 1978-02-08 1979-08-23 Fujisawa Pharmaceut Co Ltd Medicinal composition containing tiaramide or its acid addition salt, and their preparation
JPS5513239A (en) * 1978-07-14 1980-01-30 Fujisawa Pharmaceut Co Ltd Fine particulate drug composition
US4321253A (en) * 1980-08-22 1982-03-23 Beatty Morgan L Suspension of microencapsulated bacampicillin acid addition salt for oral, especially pediatric, administration
US4362730A (en) * 1980-08-25 1982-12-07 Heinrich Mack Nachf. Chem-Pharm. Fabrik Vincamine saccharinate and a pharmaceutical composition containing it dissolved therein
US4340582A (en) * 1981-01-15 1982-07-20 Abbott Laboratories Erythromycin base tablets
SE8103843L (sv) * 1981-06-18 1982-12-19 Astra Laekemedel Ab Farmaceutisk mixtur
FR2532177A1 (fr) * 1982-08-30 1984-03-02 Being Well Products Inc Complement nutritionnel a zones de liberation determinees et son procede de fabrication
US4749575A (en) * 1983-10-03 1988-06-07 Bio-Dar Ltd. Microencapsulated medicament in sweet matrix
US4708867A (en) * 1983-12-19 1987-11-24 Key Pharmaceuticals, Inc. Minipellets
IE58110B1 (en) * 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
DE3524572A1 (de) * 1985-07-10 1987-01-15 Thomae Gmbh Dr K Feste arzneimittelformen zur peroralen anwendung enthaltend 9-deoxo-11-deoxy-9,11-(imino(2-(2-methoxyethoxy)ethyliden)-oxy)-(9s)-erythromycin und verfahren zu ihrer herstellung
US4971791A (en) * 1985-08-26 1990-11-20 The Procter & Gamble Company Taste masking compositions
US5286489A (en) * 1985-08-26 1994-02-15 The Procter & Gamble Company Taste masking compositions
US4693896A (en) * 1985-10-07 1987-09-15 Fmc Corporation Ethylcellulose-coated, gastric-disintegrable aspirin tablet
US4786508A (en) * 1986-05-30 1988-11-22 Warner-Lambert Company Coated dosage forms
US4800087A (en) * 1986-11-24 1989-01-24 Mehta Atul M Taste-masked pharmaceutical compositions
KR960011236B1 (ko) * 1987-05-08 1996-08-21 스미스 클라인 앤드 프렌취 라보라토리스 리미티드 제약학적 조성물 및 고체 제형
US4916161A (en) * 1988-10-25 1990-04-10 Bristol-Myers Squibb Taste-masking pharmaceutical agents
US5084278A (en) * 1989-06-02 1992-01-28 Nortec Development Associates, Inc. Taste-masked pharmaceutical compositions
US5082669A (en) * 1989-07-20 1992-01-21 Dainippon Pharmaceutical Co., Ltd. Rapid-releasing oral particle pharmaceutical preparation with unpleasant taste masked
TW212139B (sv) * 1991-04-15 1993-09-01 Yamanouchi Pharma Co Ltd
CA2304630A1 (en) * 1997-10-03 1999-04-15 Elan Corporation, Plc Taste masked formulations
ES2224634T3 (es) * 1998-04-29 2005-03-01 Sumitomo Pharmaceuticals Company, Limited Formulacion oral que comprende biguanida y un acido organico.
JP4606582B2 (ja) * 1998-04-29 2011-01-05 大日本住友製薬株式会社 ビグアナイド系薬物の内服製剤
US6551617B1 (en) 2000-04-20 2003-04-22 Bristol-Myers Squibb Company Taste masking coating composition
DK1276470T3 (da) 2000-04-20 2007-06-18 Novartis Ag Smagskaskerende overtrækssammensætning
AU2003209673B2 (en) * 2002-03-08 2007-10-18 M/S. Ind-Swift Limited Tasteless directly compressible fast-dissolving complexes and pharmaceutical formulations thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE575775A (sv) * 1958-02-18
US3242049A (en) * 1963-05-20 1966-03-22 Ncr Co Process for making enterically useful complex of spiramycin and product thereof
US3247065A (en) * 1963-10-14 1966-04-19 Hoffmann La Roche Free-flowing coated ascorbic acid
DE1228029C2 (de) * 1964-05-09 1973-05-17 Merck Ag E Verfahren zur Herstellung von Tabletten durch Pressen von Pulvergemischen ohne vorhergehende Granulation
US3906086A (en) * 1971-07-19 1975-09-16 Richard G Powers Timed-release aspirin
JPS5214234B2 (sv) * 1971-07-30 1977-04-20
JPS523342B2 (sv) * 1972-01-26 1977-01-27
US3879511A (en) * 1972-07-03 1975-04-22 Warner Lambert Co Tasteless methenamine mandelate in a stabilized vegetable oil suspension
BE791458A (fr) * 1972-07-31 1973-05-16 Merck & Co Inc Produit microencapsule

Also Published As

Publication number Publication date
DE2604044C2 (de) 1982-12-09
NL167325B (nl) 1981-07-16
US4101651A (en) 1978-07-18
ES445014A1 (es) 1977-08-01
NL7601069A (nl) 1977-03-31
FR2325388A1 (fr) 1977-04-22
JPS5840529B2 (ja) 1983-09-06
NL167325C (nl) 1981-12-16
CA1069047A (en) 1980-01-01
GB1539076A (en) 1979-01-24
SE418146B (sv) 1981-05-11
DE2604044A1 (de) 1977-03-31
MX4338E (es) 1982-04-01
FR2325388B1 (sv) 1980-06-06
JPS5241214A (en) 1977-03-30
BE838239A (fr) 1976-05-28

Similar Documents

Publication Publication Date Title
SE7601096L (sv) Forfarande for framstellning av preparat for oral administration
GR1000358B (el) Μεθοδος για την παρασκευη φαρμακευτικων προσροφηματων.
ES8203846A1 (es) Procedimiento de preparacion de nuevos iminoacidos y de sus derivados.
SE425715B (sv) Forfarande for framstellning av ett aminosyrapreparat, avsett for administration till humanpatienter med leversjukdom
SE8406081D0 (sv) Method and composition for the preparation of controlled long-acting pharmaceuticals for oral administration
AR202034A1 (es) Procedimiento para preparar polvo farmaceutico dispersible para administracion oral de sitosteroles
KR880004806A (ko) 분무 건조 아세트아미노펜
NO860332L (no) Fremgangsmaate for fremstilling av terapeutisk aktive alfa-(2-okso-2,4,5,6,7,7a-heksahydro-tieno(3,2-c)-5-pyridyl)-fenyl-eddiksyre-derivater.
NZ222107A (en) Therapeutic powder form of spray-dried acetaminophen and ethylcellulose and pharmaceutical compositions for oral administration thereof
KR880004805A (ko) 분무건조된 아세트아미노펜
ES443616A1 (es) Procedimiento para la fabricacion de nuevos derivados 1,3- disustituidos del propanol-(2) y sus esteres de acido nico- tinico.
NL148611B (nl) Werkwijze ter bereiding van therapeutisch actieve derivaten van 7-aminocefalosporanzuur, werkwijze ter bereiding van farmaceutische preparaten, alsmede aldus verkregen gevormde voortbrengselen.
IT1060368B (it) Derivati dell'immidazolidin 2,4 dione, procedimento per la loro preparazione e loro uso come prodotti disinfestanti
NO137965C (no) Analogifremgangsmaate for fremstilling av nye cykliske terapeutisk aktive urinstoffderivater og salter av disse med farmasoeytisk akseptable syrer
NL168210B (nl) Werkwijze ter bereiding van farmaceutische preparaten, alsmede werkwijze ter bereiding van cyclische carbon- zuurderivaten.
GB630439A (en) Improvements in or relating to pharmaceutical preparations
NL7603594A (nl) Werkwijze voor het bereiden van carbonzuuramiden, alsmede de toepassing daarvan als farmaceutische preparaten.
SE420919B (sv) Forfarande for framstellning av n?722-dansyl-l-argininderivat och farmaceutiskt godtagbara syradditionssalter derav
ES400785A1 (es) Un procedimiento para preparar un medicamento que contiene en calidad de ingrediente activo adenosin-5'-monofosfato de paverina monohidratado.
NL187354C (nl) Werkwijze voor de bereiding van farmaceutische preparaten met prostaglandinewerking en werkwijze voor de bereiding van daarin bruikbare prostaglandinederivaten.
ES2047540T3 (es) Compuesto farmaceutico y procedimiento para su preparacion.
HU173879B (hu) Sposob poluchenija proizvodnykh tetrazolil- i tetrazolilalkil-imidazola i benzimidazola i farmacepticheskikh preparatov, soderzhahhikh ehti soedinenija v kachestve aktivnykh vehhestv
ES387532A1 (es) Procedimiento para fabricar un medicamento.
NO139786C (no) Analogifremgangsmaate for fremstilling av farmasoeytisk aktive n-(5-tetrazolyl)-pyrimido-(1,2-a)kinolin-2-karboksamid-derivater
MY101266A (en) Pharmaceutical formulations

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 7601096-6

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 7601096-6

Format of ref document f/p: F